Power Law company profile

ACADIA Pharmaceuticals

Biotech & Life Sciences · San Diego, United States · Founded 1993 · IPO 2004 Thoroughbred

Committed to developing treatments for neurological disorders

Valuation

$3.07B

Market cap · May/2026

Revenue

$1.07B

Latest reported FY

EBITDA

$86M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

10 investors on ACADIA Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

BankInvest

LD Pensions

DKA Capital

Series B+ 7 investors entered at this stage

NEA

Hambrecht & Quist Capital Management

LD Pensions

OrbiMed

Federated Hermes

Forbion Capital Partners

Oxford Bioscience Partners

Global footprint

Where ACADIA Pharmaceuticals has talent and traffic

AI talent share

0.3% of workforce is AI talent
(3 of 997 staff)

Core AI00%

Other AI30.3%

Non-AI workforce99499.7%

Workforce by country

13 countries with
team presence

🇺🇸 United States96%

🇨🇭 Switzerland1.4%

🇨🇦 Canada1%

🇩🇪 Germany0.3%

🇳🇱 Netherlands0.3%

Top 5 of 13 shown

Web traffic by country

52K monthly visits
across markets

🇺🇸 United States70.2%

🇨🇦 Canada6%

🇮🇹 Italy4.8%

🇬🇧 United Kingdom4.2%

🇮🇳 India3.5%

Top 5 markets shown

Market sentiment

What the market is saying about ACADIA Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about ACADIA Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ACADIA Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles